會員登入
註冊
Key Highlights:
Strong Taiwan Delegation: Nearly 46 Taiwanese companies, institutions, and research bodies participated, seeking opportunities in licensing, investment, clinical partnerships, and CDMO collaborations — rivaling the strong showing at this year’s BIO USA.Taiwan Pavilion Shines Bright:
Led by the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) and Development Center for Biotechnology (DCB), the Taiwan Pavilion featured 15 companies spanning biotech, regenerative medicine, AI, microbiome, exosome, and advanced manufacturing.Notable participants included Taiwan BIO, Amaran Biotechnology, AM Biotech, Bora Pharmaceuticals (6472), Creative Life Science (7837), Leeuwenhoek Laboratories, LumiSTAR Biotechnology, Orient EuroPharma (4120), PharmaEssentia (6446),Steminent Biotherapeutics (7729), Taiwan Bio-Manufacturing Corporation (TBMC), Taiwan Cell Manufacturing, Taiwan Green extraction Industry Alliance for Plant-Derived Natural Products, TherapiAI Innovations, Tri-Service General Hospital Innovation Incubation Center.
Cross-Border Success Stories:
TBMC secured investment and exclusive distribution in Japan from CBC Co., Ltd.Leeuwenhoek Laboratories launched its next-gen synbiotic product Flora Le Light Synbiotics in Japan.
Amaran Biotechnology formed a CDMO partnership with Nippon Fine Chemical for nanoparticle drug development.
AM Biotech joined Japan’s Cosmetic Industry Association with its high-purity exosome products.
LumiSTAR Biotechnology was selected for Takeda’s COCKPI-T® program to accelerate drug discovery.
Steminent Biotherapeutics (7729) has been recognized by Japan’s MHLW as an Accredited Foreign Manufacturer of regenerative medical products and has signed an MoU with Kohjin Bio.
Creative Life Science (7837) will sign an MoU with Myoridge, advancing cell-based regenerative medicine collaborations.
Showcasing Taiwan’s Global Biotech Strength:
Beyond the Pavilion, leading firms like EirGenix (6589), TFBS Bioscience (6939), DuoGenic StemCells (7607), Locus Cell (6891), Mycenax (4726), KriSan Biotech, Mithra Biotechnology, Alpha Intelligence Manifolds, Taiwania Capital, Green Energy Nano Technology, Bio-METS and AinoCells also presented independently or alongside Japanese partners.Moreover, over 20 Taiwanese companies engaged in one-on-one partnering sessions with global investors and industry peers.
Global Collaboration on Stage:
On October 9, Dr. Wallace, Chih-Hwa Lin (林治華), Secretary-General of Taiwan BIO, joined leaders from the U.S., U.K., France, Belgium, Germany, and Korea at the Biocluster Summit, sharing insights on Taiwan’s thriving biotech innovation ecosystem.The following day, Protuoso Biosciences, a Taiwan-based synthetic biology startup founded by Prof. Timothy Lu, joined "THE PITCH OF BJ" session to connect with investors and partners from Japan and Korea.
